Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

597

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

May 31, 2010

Conditions
Type 2 Diabetes
Interventions
DRUG

dapagliflozin

tablet oral 2.5, 5, or 10 mg total daily dose once daily 48 weeks

DRUG

Glimepiride

tablet oral 2.5, 5, or 10 mg total daily dose once daily 48 weeks

DRUG

metformin hydrochloride

rescue medication oral dosing in accordance with the manufacturer's recommendations and clinical practice

DRUG

pioglitazone hydrochloride

rescue medication oral dosing in accordance with the manufacturer's recommendations and clinical practice

DRUG

Rosiglitazone

rescue medication oral dosing in accordance with the manufacturer's recommendations and clinical practice

Trial Locations (66)

Unknown

Research Site, Blansko

Research Site, Bruntál

Research Site, Břeclav

Research Site, Hodonín

Research Site, Ostrava - Belsky Les

Research Site, Pilsen

Research Site, Prague

Research Site, Pribram VIII

Research Site, Rakovník

Research Site, Semily

Research Site, Balatonfüred

Research Site, Békéscsaba

Research Site, Budapest

Research Site, Csongrád

Research Site, Eger

Research Site, Gyöngyös

Research Site, Kecskemét

Research Site, Makó

Research Site, Miskolc

Research Site, Mosonmagyaróvár

Research Site, Siófok

Research Site, Szentes

Research Site, Tát

Research Site, Zalaegerszeg

Research Site, Cebu City

Research Site, Manila

Research Site, Marikina City

Research Site, Pasig

Research Site, Bielsko-Biala

Research Site, Bydgoszcz

Research Site, Chojnice

Research Site, Chrzanów

Research Site, Ciechocinek

Research Site, Czechowice-Dziedzice

Research Site, Elblag

Research Site, Gdansk

Research Site, Gniewkowo

Research Site, Grudziądz

Research Site, Iława

Research Site, Krakow

Research Site, Mrągowo

Research Site, Poznan

Research Site, Płock

Research Site, Ruda Śląska

Research Site, Sopot

Research Site, Torun

Research Site, Wroclaw

Research Site, Zabrze

Research Site, Zielona Góra

Research Site, Żory

Research Site, Wŏnju

Research Site, Suwon

Research Site, Jeonju

Research Site, Bucheon-si

Research Site, Incheon

Research Site, Seongnam

Research Site, Seoul

Research Site, Uljeongbu

Research Site, Bangkok

Research Site, Chiang Mai

Research Site, Dnipropetrov'sk

Research Site, Donetsk

Research Site, Kharkiv

Research Site, Kiev

Research Site, Vinnytsia

Research Site, Zaporizhzhya

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY